Functionally Active Gap Junctions between Connexin 43-Positive Mesenchymal Stem Cells and Glioma Cells

Verfasser / Beitragende:
[A. Gabashvili, V. Baklaushev, N. Grinenko, A. Levinskii, P. Mel'nikov, S. Cherepanov, V. Chekhonin]
Ort, Verlag, Jahr:
2015
Enthalten in:
Bulletin of Experimental Biology and Medicine, 159/1(2015-05-01), 173-179
Format:
Artikel (online)
ID: 60553473X
LEADER caa a22 4500
001 60553473X
003 CHVBK
005 20210128100844.0
007 cr unu---uuuuu
008 210128e20150501xx s 000 0 eng
024 7 0 |a 10.1007/s10517-015-2916-7  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10517-015-2916-7 
245 0 0 |a Functionally Active Gap Junctions between Connexin 43-Positive Mesenchymal Stem Cells and Glioma Cells  |h [Elektronische Daten]  |c [A. Gabashvili, V. Baklaushev, N. Grinenko, A. Levinskii, P. Mel'nikov, S. Cherepanov, V. Chekhonin] 
520 3 |a The formation of functional gap junctions between mesenchymal stem cells and cells of low-grade rat glioma C6 cells was studied in in vitro experiments. Immunocytochemical analysis with antibodies to connexin 43 extracellular loop 2 showed that mesenchymal stem cells as well as C6 glioma cells express the main astroglial gap junction protein connexin 43. Analysis of migration activity showed that mesenchymal stem cells actively migrate towards C6 glioma cells. During co-culturing, mesenchymal stem cells and glioma C6 form functionally active gap junctions mediating the transport of cytoplasmic dye from glioma cells to mesenchymal stem cells in the opposite direction. Fluorometry showed that the intensity of transport of low-molecular substances through heterologous gap junctions between mesenchymal stem cells and glioma cells is similar to that through homologous gap junctions between glioma cells. This phenomenon can be used for the development of new methods of cell therapy of high-grade gliomas. 
540 |a Springer Science+Business Media New York, 2015 
690 7 |a mesenchymal stem cells  |2 nationallicence 
690 7 |a glioblastoma multiforme  |2 nationallicence 
690 7 |a C6 glioma  |2 nationallicence 
690 7 |a connexin 43  |2 nationallicence 
690 7 |a gap junctions  |2 nationallicence 
700 1 |a Gabashvili  |D A.  |u Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov Russian National Research Medical University, Moscow, Russia  |4 aut 
700 1 |a Baklaushev  |D V.  |u Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov Russian National Research Medical University, Moscow, Russia  |4 aut 
700 1 |a Grinenko  |D N.  |u Department of Fundamental and Applied Neurobiology, V. P. Serbsky State Research Center of Forensic and Social Psychiatry, Moscow, Russia  |4 aut 
700 1 |a Levinskii  |D A.  |u Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov Russian National Research Medical University, Moscow, Russia  |4 aut 
700 1 |a Mel'nikov  |D P.  |u Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov Russian National Research Medical University, Moscow, Russia  |4 aut 
700 1 |a Cherepanov  |D S.  |u Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov Russian National Research Medical University, Moscow, Russia  |4 aut 
700 1 |a Chekhonin  |D V.  |u Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov Russian National Research Medical University, Moscow, Russia  |4 aut 
773 0 |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 159/1(2015-05-01), 173-179  |x 0007-4888  |q 159:1<173  |1 2015  |2 159  |o 10517 
856 4 0 |u https://doi.org/10.1007/s10517-015-2916-7  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10517-015-2916-7  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Gabashvili  |D A.  |u Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov Russian National Research Medical University, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Baklaushev  |D V.  |u Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov Russian National Research Medical University, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Grinenko  |D N.  |u Department of Fundamental and Applied Neurobiology, V. P. Serbsky State Research Center of Forensic and Social Psychiatry, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Levinskii  |D A.  |u Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov Russian National Research Medical University, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Mel'nikov  |D P.  |u Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov Russian National Research Medical University, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Cherepanov  |D S.  |u Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov Russian National Research Medical University, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Chekhonin  |D V.  |u Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov Russian National Research Medical University, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 159/1(2015-05-01), 173-179  |x 0007-4888  |q 159:1<173  |1 2015  |2 159  |o 10517